# Current Readiness State (One-Pager)

**Date:** 2026-03-08  
**Release Lane:** `v0.0.0-test`  
**Overall Decision:** **GO**

## Executive Summary
HDIM is currently in a **GO** state for pilot-readiness and investor diligence based on no-waiver release controls, current-cycle evidence, and closed high-priority compliance gaps.

## Gate Status
| Gate | Status | Evidence |
|---|---|---|
| Regulatory readiness | GO | `docs/releases/v0.0.0-test/validation/regulatory-readiness-report.md` |
| Investor readiness | GO | `docs/investor/INVESTOR_READINESS_REVIEW_2026-03-08.md` |
| Evidence freshness + no-waiver controls | GO | `docs/releases/v0.0.0-test/validation/evidence-freshness-report.md` |
| Release scorecard | GO | `docs/compliance/RELEASE_READINESS_SCORECARD_2026-03-07.md` |
| Regulatory control matrix | PASS across listed controls | `docs/compliance/REGULATORY_CONTROL_MATRIX_2026-03-07.md` |

## Gap Closure Snapshot
- `GAP-001` (CI gate freshness): **Closed**
- `GAP-002` (DR evidence): **Closed**
- `GAP-003` (access governance): **Closed**
- `GAP-004` (third-party risk): **Closed**

Reference: `docs/compliance/GAP_REGISTER_2026-03-07.md`

## Decision Policy
- Pilot-readiness lane runs a **no-waiver** policy for critical controls.
- Missing or stale evidence defaults to **NO-GO**.

Reference: `docs/releases/AI_HUMAN_RELEASE_ORCHESTRATION.md`

## Immediate Next 24h Focus
1. Finalize pilot KPI baseline and target values.
2. Complete clinical safety cases for top risk workflows.
3. Lock customer-facing go-live packet for review.
